Interaction Between an 11βHSD1 Gene Variant and Birth Era Modifies the Risk of Hypertension in Pima Indians
Authors:
- Paul W. FranksPFPaul W. Franks
- William C. KnowlerWKWilliam C. Knowler
- Saras NairSNSaras Nair
- Juraj KoskaJKJuraj Koska
- Yong-Ho LeeYLYong-Ho Lee
- Robert S. LindsayRLRobert S. Lindsay
- Brian R. WalkerBWBrian R. Walker
- Helen C. LookerHLHelen C. Looker
- Paska A. PermanaPPPaska A. Permana
- P. Antonio TataranniPTP. Antonio Tataranni
- Robert L. HansonRHRobert L. Hanson
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (5) , 681-688
Abstract
11β-Hydroxysteroid dehydrogenase type 1 (11βHSD1) is a candidate gene for hypertension, diabetes, and obesity through altered glucocorticoid production. This study explored the association of 11βHSD1 gene variants with diabetes, hypertension, and obesity in a longitudinal population study of American Indians (N=918; exams=5508). In multivariate mixed models assuming an additive effect of genotype, a 5′ upstream variant (rs846910) was associated with blood pressure (diastolic blood pressure β=1.58 mm Hg per copy of the A allele, P =0.0008; systolic blood pressure β=2.28 mm Hg per copy of the A allele, P =0.004; mean arterial blood pressure β=1.83 mm Hg per copy of the A allele, P =0.0006) and hypertension (odds ratio=1.27 per copy of the A allele, P =0.02). However, birth date modified these associations (test for interaction: diastolic blood pressure P =0.16; systolic blood pressure P =0.007; mean arterial blood pressure P =0.01), such that the magnitude and direction of association between genotype and blood pressure changed with time. Finally, in models controlling for potential confounding by population stratification, we observed evidence of within-family effects for blood pressure (diastolic blood pressure β=1.77 mm Hg per copy of the A allele, P =0.004; systolic blood pressure β=2.04 mm Hg per copy of the A allele, P =0.07; mean arterial blood pressure β=1.85 mm Hg per copy of the A allele, P =0.01) and for hypertension (odds ratio=1.26 per copy of the A allele; P =0.08). No association was observed for obesity. Associations with diabetes were similar in magnitude as reported previously but were not statistically significant. These data demonstrate association between genetic variability at 11βHSD1 with hypertension, but these effects are modified by environmental factors.Keywords
This publication has 22 references indexed in Scilit:
- Nonreplication in Genetic Association Studies of Obesity and Diabetes ResearchThe Journal of Nutrition, 2003
- Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and CaucasiansThe Journal of Clinical Endocrinology & Metabolism, 2003
- Population stratification and spurious allelic associationThe Lancet, 2003
- Establishing the role of gene-environment interactions in the etiology of type 2 diabetesEndocrinology and Metabolism Clinics of North America, 2002
- Publication Bias in Editorial Decision MakingJAMA, 2002
- A comprehensive review of genetic association studiesGenetics in Medicine, 2002
- Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null MiceJournal of Biological Chemistry, 2001
- Minireview: 11β-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action1Endocrinology, 2001
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997
- Does central obesity reflect “Cushing's disease of the omentum”?The Lancet, 1997